CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.37, no.6, pp.93-97, 2019 (SCI-Expanded)
Objective. To evaluate differences between the patients with familial Mediterranean fever (FMF) with homozygous (Hom), heterozygous (Het) and compound heterozygous (cHet) MEFV mutations in terms of clinical features and severity of the disease, as well as frequency of concomitant disorders, without focusing on Exon 10 mutations.